Unlocking the potential of Ultrasound
There are nearly 50 million medical practitioners in the world, most of whom do not have the skills required to scan with ultrasound.
Our intelligent ultrasound software and simulation platforms aim to train, guide, support and ultimately enable automated ultrasound scanning for every medical practitioner.
clinical training
through simulation
Based in Cardiff (UK) and Atlanta (USA), the intelligent ultrasound simulation division focuses on hi-fidelity ultrasound education and training through simulation.
Its three main products are the ScanTrainer, HeartWorks and BodyWorks.
INTELLIGENT ULTRASOUND
Clinical guidance
& image analysis
Based in Oxford (UK), the intelligent ultrasound clinical support division develops augmented reality and deep-learning based algorithms to improve clinical guidance and image analysis in ultrasound.
Products in development include ScanNav and NeedleGuide.
AIM Rule 26
The following information is being disclosed for the purposes of Rule 26 of the AIM Rules for Companies. Last updated 26 September 2018.
_____________________
Directors and Committees
Please click here for the names, responsibilities and brief biographies of our Directors including details of committees and their members.
_____________________
Country of incorporation and main country of operation
Country of Incorporation: England and Wales
Registered office: The Medicentre, Heath Park, Cardiff, Wales CF14 4UJ
Company Registration Number: 09028611
Main Country of Operation: United Kingdom
_____________________
About Intelligent Ultrasound Group plc
Intelligent Ultrasound Group plc is headquartered in Cardiff, UK and has offices in Oxford, UK and Alpharetta, GA, USA. The Group’s customers are some of the world’s leading medical institutions. Our guiding principle is to develop world-class ultrasound software and simulation technologies that will improve the quality and speed of ultrasound scanning in the clinical environment.
Intelligent Ultrasound Group plc (formerly MedaPhor Group plc) was admitted to the Alternative Investment Market (AIM) of the London Stock Exchange on 27 August 2014.
The Group’s trading subsidiaries are:
MedaPhor Limited (which took over the operations of fellow subsidiary, Inventive Medical Limited on 1st January 2019)
Intelligent Ultrasound Limited
MedaPhor North America Inc.
MedaPhor Group plc is subject to the UK City Code on Takeovers and Mergers.
_____________________
Details of any other exchanges or trading platforms
The Company is not listed on any other exchanges or trading platforms.
_____________________
Details of any restrictions on the transfer of securities
There are no restrictions on the transfer of securities.
_____________________
Number of securities in issue
Please click here for the number of securities in issue, the number of securities held as treasury shares and, insofar as the Company is aware, the percentage of securities that is not in public hands together with the identity and percentage holdings of significant shareholders.
_____________________
Company reports
Please click here for our last annual report and all subsequent reports.
_____________________
Notifications
Please click here for details of all notifications made in the past twelve months.
_____________________
Advisors
Please click here for details of the Company’s Nominated Advisor and other key advisors.
_____________________
Corporate Governance
Please click here for a link to a statement on the Company’s application of the principles of the QCA Corporate Governance Code.
Articles of Association
Download our Articles of Association
Admission Document
Document in respect of the company’s admission to AIM on 27th August 2014
Download our Admission